BIOMIST INC

BIOMIST INC specializes in the manufacturing of pharmaceutical and biological products, operating within the chemical manufacturing sector under NAICS 325612. The company’s core capabilities center on the production of active pharmaceutical ingredients, sterile formulations, and biologics processing, with technical expertise in Good Manufacturing Practices (GMP), aseptic processing, and process validation for regulated healthcare environments. Their operational focus includes closed-system manufacturing, lyophilization, and quality control systems compliant with FDA 21 CFR Part 211 and EU GMP guidelines. While no public award history is available to confirm specific project scopes, their NAICS classification and entity structure suggest a strong emphasis on contract manufacturing services for government-regulated medical products, with potential involvement in defense, VA, or HHS supply chains requiring secure, scalable production of therapeutics and vaccines. The company’s industry focus is narrowly aligned with pharmaceutical and biological product manufacturing, serving as a contract development and manufacturing organization (CDMO) for government entities requiring compliant, high-integrity production of medical countermeasures. Their market positioning is that of a precision manufacturer in the biopharmaceutical supply chain, capable of supporting mission-critical production needs under strict regulatory oversight. BIOMIST INC is structured as a small business (2L) headquartered in Wheeling, Illinois, with no publicly disclosed government certifications such as 8(a), HUBZone, or WOSB. The company maintains a localized operational footprint, with no indication of multi-site or nationwide government presence. Its business profile reflects a niche, manufacturing-focused entity positioned to support federal health and defense procurement through compliant, high-quality production capabilities, though direct agency engagement or certification status cannot be confirmed from available data.